STAT Plus: Editas CEO resigns, raising questions about a series of executive departures at nascent CRISPR company
JONATHAN WIGGS/THE BOSTON GLOBE
One investor with no position in Editas said Bosley struggled to connect with health care investment funds; the company’s owners are largely mutual funds.
.jpeg)
No hay comentarios:
Publicar un comentario